Try our Advanced Search for more refined results
Securities and Exchange Commisison v. Blech et al
Case Number:
1:12-cv-03703
Court:
Nature of Suit:
Judge:
Firms
-
August 23, 2013
'King Of Biotech' Settles Stock Manipulation Case For $1M
Biotech financier David A. Blech will pay $1.03 million in disgorgement for his role in a scheme to manipulate stock prices, according to a settlement with federal regulators approved by a New York federal judge Thursday.
-
May 10, 2012
SEC Hits Biotech Investor With Market Manipulation Suit
Biotechnology financier David Blech, who pled guilty Wednesday to securities fraud for manipulating the stock prices of two biotech companies, will now have to face off with the U.S. Securities and Exchange Commission over the same scheme.